We recently identified S14161, or 8-ethoxy-2-(4-fluorophenyl)-3 -nitro-2H-chromene, as a novel PI3K inhibitor, that displays promising effects against multiple myeloma and leukemia cells with minimal toxicity [23]. The gene discussed is PIK3CD; the disease is leukemia.